NIH Clinical Center (CC)

Critical care cardiology (CCC) is an evolving specialty requiring advanced training and expertise. A new report from a scientific expert panel provides a detailed guide for trainees, offering valuable insights into the current landscape of CCC. The report addresses key challenges and outlines future directions to advance education and practice in this critical field. ?? Read the full article: https://lnkd.in/eTGQ4U6u #criticalcarecardiology

Thanks to all the #NIH institute and center directors who came out to play some cornhole at the CFC Director’s Challenge at the NIH Clinical Center (CC) ! NIH staff are major contributors to the Combined Federal Campaign (CFC), giving more than $2 million last year to charity organizations.

Excellent resources for families and caregivers of patients with rare cancers.

We are thrilled to announce that The National Institutes of Health Clinical Center has earned Magnet with Distinction recognition from the American Nurses Credentialing Center’s Magnet Recognition Program! This esteemed honor highlights our commitment to nursing excellence, collaborative practice, and exceptional patient care. Only about 10% of U.S. hospitals achieve Magnet recognition, and less than 1% of those hospitals earn the prestigious Magnet with Distinction designation! Chief Nurse Officer Dr. Barbara Jordan shared, “This recognition reflects the dedication and expertise of our entire NIH Clinical Center team and underscores our unwavering commitment to excellence in patient care.” Achieving Magnet status is a rigorous process involving a comprehensive evaluation of our patient care practices, an on-site visit, and a thorough review. We are proud to be part of the global community of Magnet hospitals! Congratulations to our outstanding nursing team! #MagnetWithDistinction #NursingExcellence #PatientCare #MagnetRecognition #CelebratingSuccess

We recently welcomed second-year nursing students from South Korea for a Clinical Center tour as part of their overseas study experience. Office of Communications and Media Relations Team Lead Donovan Kuehn led the tour.

I like posting about Results and Events, but sometimes INITIATING a new program is worth shouting about. And here's a perfect example with a compelling story. At our National Center for Advancing Translational Sciences (NCATS) labs we've announced our commitment to developing the gene therapy MMA-101 to treat methylmalonic acidemia (MMA) associated with loss of the MMUT gene (via AAV8). MMA-101 was initially developed by disease expert Chuck Venditti at NHGRI who has dedicated his career to studying MMA. This therapeutic candidate has quite the tale. Originally licensed to Selecta, the company continued the development in partnership with Venditti and filed an IND. Weeks before the first MMA clinical trial participant was to receive the gene therapy at the NIH Clinical Center (CC), the company halted the project for financial reasons. What to do? Selecta generously handed back the technology, data, and gene therapy material to NIH when they stepped away. The opportunity for the patient community is too great to allow this to simply lie fallow, so we've committed over $2 million to get MMA-101 to patients, and our team will provide overall project coordination, expertise on clinical product storage, and MMA-101 stability testing. NCATS also will help with organizing trial startup activities, including regulatory document preparation and review. The trial will be lead by Chuck Venditti , and a host of other NIH institutes will be working with us (NINDS, NICHD, Clinical Center) - all detailed in the news item below by Steven Benowitz. Our intramural team for MMA-101 includes Rodica Stan, PhD, Richa Madan Lomash, PhD, and Elizabeth Ottinger . Without all these NIH partners working together, this potential treatment may never reach patients.

CNN’s Meg Tirrell takes a closer look at the research led by Dr. Kevin Hall and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) happening at the Clinical Center.

We had a blast at The National Institutes of Health Directors' Challenge Cornhole Tournament, where IC Directors brought their A-game in a fun and friendly competition that energized the crowd and raised awareness for this year's Combined Federal Campaign (CFC). Thank you to everyone who joined us in the Clinical Center Atrium to cheer them on and celebrate the?Give Happy?spirit! ? The Clinical Center is proud to be the lead NIH IC for the 2024 CFC! The CFC is the federal government's largest workplace giving Campaign, offering an easy and efficient way to support causes with over 4,500 local, national, and international charities. ? The CFC runs until January 15, 2025—for all NIH staff, there's still time to give! #CFC2024 #GiveHappy #DirectorsChallenge

What does it take to improve outcomes for children? Dr. Louis M. Bell, a leader in pediatric medicine, shares key lessons and strategies from his decades of experience in his November 13th Clinical Center Grand Rounds Great Teacher Lecture. Don't miss his insights on advancing care for children! Lessons Learned in the Path Towards Improving Outcomes for Children. Watch the full lecture: https://lnkd.in/eyZcAFrE #nihccgrandrounds #childrenshealth #raredisease

Construction Update! Construction Progress on the Clinical Center’s state-of-the-art Surgery, Radiology, and Laboratory Medicine (SLRM) Wing. Welcome to the future of the NIH Clinical Center's patient care and biomedical research! As the largest hospital devoted entirely to clinical research, the NIH Clinical Center is modernizing to ensure we continue providing world-class care and groundbreaking research. Spanning 547,290 square feet, this state-of-the-art facility will bring together critical departments—Perioperative Medicine, Radiology and Imaging Sciences, and Laboratory Medicine—while expanding spaces for the National Cancer Institute (NCI) and the National Heart, Lung, and Blood Institute (NHLBI).